Dharmacon to deliver First Whole Human Genome-Wide siRNA Library

18-May-2005 - Dharmacon, Inc. announced an agreement to deliver a genome-wide short-interfering RNA (siRNA) library covering approximately 22.000 human genes to Millennium Pharmaceuticals, Inc. This library, the first siRNA collection targeting genes across the entire human genome, was developed using ...

Fisher Scientific to Divest Atos Medical AB

10-Mar-2005 - Fisher Scientific International Inc. announced that it has signed a definitive agreement to sell Atos Medical AB, a manufacturer of ear, nose and throat medical devices with 2004 sales totaling $35 million, to Nordic Capital for $110 million in cash. Acquired by Fisher in its 2003 transaction ...

Dharmacon RNAi Technology Selected by Genentech to support Drug Discovery Research

07-Feb-2005 - Dharmacon, Inc. announced that Genentech, Inc. has selected Dharmacon's advanced RNAi technology for use in its drug discovery and development research. Under an agreement between the two companies, Dharmacon will supply Genentech with a range of siRNA reagents including Dharmacon's Human ...

Dharmacon Announces Agreement to be Acquired by Fisher Scientific

Acquisition Gives Dharmacon's Leading RNA Interference Technology Expanded Access to Global Research Markets -

12-Feb-2004 - Dharmacon, Inc., of Lafayette, Colorado, the leading global supplier of innovative RNA and RNA-interference research (RNAi) products, today announced that it has signed a definitive agreement to be acquired by Fisher Scientific International Inc. (NYSE:FSH) , a leading global provider of ...